BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 34255033)

  • 1. Autoimmune- and complement-mediated hematologic condition recrudescence following SARS-CoV-2 vaccination.
    Portuguese AJ; Sunga C; Kruse-Jarres R; Gernsheimer T; Abkowitz J
    Blood Adv; 2021 Jul; 5(13):2794-2798. PubMed ID: 34255033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 vaccination and ITP in patients with de novo or preexisting ITP.
    Lee EJ; Beltrami-Moreira M; Al-Samkari H; Cuker A; DiRaimo J; Gernsheimer T; Kruse A; Kessler C; Kruse C; Leavitt AD; Lee AI; Liebman HA; Newland AC; Ray AE; Tarantino MD; Thachil J; Kuter DJ; Cines DB; Bussel JB
    Blood; 2022 Mar; 139(10):1564-1574. PubMed ID: 34587251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemolysis induced by SARS-CoV-2 mRNA vaccination in patients with paroxysmal nocturnal hemoglobinuria.
    Kamura Y; Sakamoto T; Yokoyama Y; Nishikii H; Sakata-Yanagimoto M; Chiba S; Obara N
    Int J Hematol; 2022 Jul; 116(1):55-59. PubMed ID: 35668275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Severe thrombocytopenia after COVID-19 mRNA vaccination].
    Hagihara M; Uchida T; Inoue M; Ohara S; Imai Y
    Rinsho Ketsueki; 2021; 62(12):1684-1687. PubMed ID: 35022337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoimmune haemolytic anaemia and immune thrombocytopenia following SARS-CoV-2 and non-SARS-CoV-2 vaccination: 32 Years of passive surveillance data.
    Jacobs JW; Booth GS; Guarente J; Schlafer D; Zheng L; Adkins BD
    Br J Haematol; 2023 Apr; 201(2):227-233. PubMed ID: 36564040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recommendations on the Management of Patients with Immune Thrombocytopenia (ITP) in the Context of SARS-CoV-2 Infection and Vaccination: Consensus Guidelines from a Spanish ITP Expert Group.
    González-López TJ; Bárez A; Bernardo-Gutiérrez A; Bernat S; Canaro-Hirnyk M; Entrena-Ureña L; Fernández-Fuertes F; Guinea de Castro JM; Jiménez-Bárcenas R; Pascual-Izquierdo C; Sánchez-González B; Jarque I
    Infect Dis Ther; 2023 Feb; 12(2):303-315. PubMed ID: 36520323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement Mediated Hemolytic Anemias in the COVID-19 Era: Case Series and Review of the Literature.
    Fattizzo B; Pasquale R; Bellani V; Barcellini W; Kulasekararaj AG
    Front Immunol; 2021; 12():791429. PubMed ID: 34899761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secondary immune thrombocytopenia supposedly attributable to COVID-19 vaccination.
    Fueyo-Rodriguez O; Valente-Acosta B; Jimenez-Soto R; Neme-Yunes Y; Inclán-Alarcón SI; Trejo-Gonzalez R; García-Salcido MÁ
    BMJ Case Rep; 2021 May; 14(5):. PubMed ID: 34059544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of COVID-19 vaccination on platelet counts and bleeding in children, adolescents, and young adults with immune thrombocytopenia.
    Kaicker S; Martinko K; Bussel JB
    Pediatr Blood Cancer; 2023 Jan; 70(1):e30051. PubMed ID: 36317671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-world, single-center experience of SARS-CoV-2 vaccination in immune thrombocytopenia.
    Woolley P; Tailor A; Shah R; Westwood JP; Scully M
    J Thromb Haemost; 2022 Jun; 20(6):1476-1484. PubMed ID: 35313390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seroconversion to mRNA SARS-CoV-2 vaccines in patients with autoimmune cytopenias and bone marrow failures.
    Fattizzo B; Bortolotti M; Giannotta JA; Consonni D; Cantoni S; Barcellini W
    Sci Rep; 2022 May; 12(1):7743. PubMed ID: 35546175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics in immune thrombocytopenia patients after COVID-19 vaccination.
    Feng Y; Quan Y; Cassady K; Zou Z; Gao Y; Zhang X
    Hum Vaccin Immunother; 2022 Nov; 18(6):2119043. PubMed ID: 36069667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of SARS-CoV-2 vaccination in patients with immune thrombocytopenia: A two-centre review.
    Stefani S; Buti N; Hart ACJ; Paul D; Rizvi N; Ragoonanan V; Vladescu C; Szydlo R; Ademokun C; Jansen AJG; Cooper N
    Br J Haematol; 2024 Jan; 204(1):324-328. PubMed ID: 38013240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the Vaccine Adverse Event Reporting System (VAERS).
    Welsh KJ; Baumblatt J; Chege W; Goud R; Nair N
    Vaccine; 2021 Jun; 39(25):3329-3332. PubMed ID: 34006408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anaphylaxis is a rare reaction in COVID-19 vaccination.
    Bellomo RG; Gallenga CE; Caraffa A; Tetè G; Ronconi G; Conti P
    J Biol Regul Homeost Agents; 2021; 35(3):839-842. PubMed ID: 34105336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B and T cell response to SARS-CoV-2 vaccination in health care professionals with and without previous COVID-19.
    Zollner A; Watschinger C; Rössler A; Farcet MR; Penner A; Böhm V; Kiechl SJ; Stampfel G; Hintenberger R; Tilg H; Koch R; Antlanger M; Kreil TR; Kimpel J; Moschen AR
    EBioMedicine; 2021 Aug; 70():103539. PubMed ID: 34391087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies to Prevent SARS-CoV-2-Mediated Eosinophilic Disease in Association with COVID-19 Vaccination and Infection.
    Simon HU; Karaulov AV; Bachmann MF
    Int Arch Allergy Immunol; 2020; 181(8):624-628. PubMed ID: 32544911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acquired aplastic anemia following SARS-CoV-2 vaccination.
    Röth A; Bertram S; Schroeder T; Haverkamp T; Voigt S; Holtkamp C; Klump H; Wörmann B; Reinhardt HC; Alashkar F
    Eur J Haematol; 2022 Aug; 109(2):186-194. PubMed ID: 35592930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The level of protective post-vaccination antibodies in NIPH-NIH employees after administration of Pfizer vaccine against COVID-19.
    Rastawicki W; Płaza K
    Przegl Epidemiol; 2021; 75(1):3-13. PubMed ID: 34328282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Case of Immune Thrombocytopenia After BNT162b2 mRNA COVID-19 Vaccination.
    King ER; Towner E
    Am J Case Rep; 2021 Jul; 22():e931478. PubMed ID: 34285180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.